Tuning insulin receptor signaling using de novo-designed agonists
Molecular Cell · 2025
DOI: 10.1016/j.molcel.2025.09.020 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Cell, 2025. Verfasst von Xinru Wang und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, University of Washington, Seattle, WA, USA; Institute for Protein Design, University of Washington, Seattle, WA, USA. Ele…. Hauptthemen laut MEDLINE: Receptor, Insulin, Hypoglycemic Agents. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, University of Washington, Seattle, WA, USA; Institute for Protein Design, University of Washington, Seattle, WA, USA. Electronic address: xinruw7@uw.edu.
- Department of Pathology and Cell Biology, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA.
- Department of Biophysics, University of Texas Southwestern Medical Center, Dallas, TX, USA.
- Department of Biochemistry, University of Washington, Seattle, WA, USA; Institute for Protein Design, University of Washington, Seattle, WA, USA; Graduate Program in Biological Physics, Structure and Design, University…
- Department of Biochemistry, University of Washington, Seattle, WA, USA; Institute for Protein Design, University of Washington, Seattle, WA, USA.
- Department of Biochemistry, University of Washington, Seattle, WA, USA; Institute for Protein Design, University of Washington, Seattle, WA, USA; Department of Genome Sciences, University of Washington, Seattle, WA, USA.
Förderung
- NIGMS NIH HHS
- NIDDK NIH HHS
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Institute of General Medical Sciences
- Cancer Prevention and Research Institute of Texas
- Irma T Hirschl Trust
- Howard Hughes Medical Institute
- Audacious Project
Zitieren
APA
Wang, X., Cardoso, S., Cai, K., Venkatesh, P., Hung, A., Ng, M., Hall, C., Coventry, B., Lee, D. S., Chowhan, R., Gerben, S., Li, J., An, W., Hon, M., Gao, M., Liao, Y. C., Accili, D., Choi, E., Bai, X. C., & Baker, D. (2025). Tuning insulin receptor signaling using de novo-designed agonists. Molecular Cell. https://doi.org/10.1016/j.molcel.2025.09.020
Vancouver
Wang X, Cardoso S, Cai K, Venkatesh P, Hung A, Ng M, et al. Tuning insulin receptor signaling using de novo-designed agonists. Molecular Cell. 2025. doi:10.1016/j.molcel.2025.09.020
BibTeX
@article{Wang2025,
author = {Wang, Xinru and Cardoso, Sarah and Cai, Kai and Venkatesh, Preetham and Hung, Albert and Ng, Michelle and Hall, Catherine and Coventry, Brian and Lee, David S and Chowhan, Rishabh and Gerben, Stacey and Li, Jie and An, Weidong and Hon, Mara and Gao, Michael and Liao, Ya-Cheng and Accili, Domenico and Choi, Eunhee and Bai, Xiao-Chen and Baker, David},
title = {Tuning insulin receptor signaling using de novo-designed agonists},
journal = {Molecular Cell},
year = {2025},
doi = {10.1016/j.molcel.2025.09.020}
}
EUVIMED